Goldman Sachs Adds Vitamin Shoppe (VSI) to Conviction Buy List; Sees 24% Upside
Tweet Send to a Friend
Goldman Sachs upgraded Vitamin Shoppe (NYSE: VSI) from Buy to Conviction Buy with a price target of $65.00 (from $59.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
